Sensei Biotherapeutics
Stock Forecast, Prediction & Price Target
Sensei Biotherapeutics Financial Estimates
Sensei Biotherapeutics Revenue Estimates
Sensei Biotherapeutics EBITDA Estimates
Sensei Biotherapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
Net Income
% change YoY
| $-37.46M N/A | $-48.80M -30.27% | $-34.10M 30.13% | Avg: $-41.28M Low: $-36.89M High: $-25.43M avg. -21.07% | Avg: $-48.29M Low: $-34.95M High: $-28.23M avg. -16.97% | Avg: $-38.57M Low: $-38.57M High: $-38.57M avg. 20.13% | Avg: $-38.57M Low: $-38.57M High: $-38.57M avg. 0% |
EBITDA
% change YoY
| $-35.99M N/A | $-50.18M -39.42% | $-33.38M 33.47% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.35 N/A | -$1.59 -17.77% | -$1.22 23.27% | Avg: -$1.17 Low: -$1.32 High: -$0.91 avg. 4.04% | Avg: -$1.12 Low: -$1.25 High: -$1.01 avg. 4.59% | Avg: -$1.38 Low: -$1.38 High: -$1.38 avg. -23.55% | Avg: -$1.38 Low: -$1.38 High: -$1.38 avg. 0% |
Operating Expenses
% change YoY
| $37.48M N/A | $50.18M 33.89% | $37.06M -26.14% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Sensei Biotherapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -4.48% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -36.89M, average is -41.28M and high is -25.43M.
What is Sensei Biotherapeutics stock revenue growth forecast?
We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Sensei Biotherapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -3.73% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.32, average is -$1.17 and high is $-0.91.
What is the best performing analyst?
In the last twelve months analysts have been covering Sensei Biotherapeutics stock. The most successful analyst is Sudan Loganathan.